GAL and Alzheimer disease: Regarding these galectins that we chose in this experiment, the protein and mRNA of gal-1 were reported by Correa et al. to be increased in patients with AD [25] and in another study by the same group, recombinant gal-1 was successfully used as a therapeutic agent in the AD induced in mice [26].